The Telegraph: Co-op unveils £206m hit from cyber attack. IT shutdown led to data from retailers’ 6.5 million members being stolen
Comment: It would appear that either companies will never learn about the dangers of hacking, or are complacent. A third scenario is that there is nothing that can be done about it. But no one, especially the cyber security companies, wants to admit it?
Blencowe Resources (BRES) announced the first batch of assay results from its Stage 7 drilling programme at its Orom-Cross graphite project in Northern Uganda. This campaign, the largest in the Company’s history, included geotechnical holes, infill drilling and exploration drilling across both the Camp Lode and Northern Syncline deposits, as well step-out and deep drilling at the newly identified Beehive deposit. BRES said “Assays are being processed in batches for each component of the programme and will be reported regularly as results are returned. The first results, from the eight geotechnical holes drilled primarily to support pit design, have returned strong graphite grades. These results confirm extensions to mineralisation and highlight high-grade zones within the existing deposits, further underscoring Orom-Cross’s unique combination of high grade, shallow ore and large-scale potential.”
Comment: BRES looks to be on its way, both on and in the ground, and in terms of the share price and the high grades at Orom-Cross. This could be timely if rumours that the seller is completely out – never to return.
Raspberry Pi (RPI), a leader in low-cost, high-performance computing, announced the launch of the Raspberry Pi 500+ all-in-one keyboard computer, and its partnership with NComputing, a global authority in end-user computing solutions, targeting the enterprise market. Windows 10 support ends in October 2025, and over 40% of business PCs cannot migrate to Windows 11, representing tens of millions of devices at risk of security gaps and costly refresh cycles. Raspberry Pi 500+ offers enterprises a low-cost, secure, and easily deployed desktop replacement. The computer combines a powerful quad-core 64-bit Arm processor, 16 GB RAM, and swappable SSD in a compact, ergonomic keyboard with integrated Wi-Fi®, Bluetooth, and Gigabit Ethernet, delivering enterprise performance at a fraction of the traditional PC cost.
Comment: Ironically, 25 years after Y2K, we actually have a cliff edge in technology that could be if not disruptive, rather expensive. Of course, the Windows 10 debacle is a way of getting people to buy new hardware, and RPI is being both canny and opportunistic in this respect.
Time To ACT plc (AQSE: TTA), an engineering-led group focused on technology for the energy transition supply chain, announced its audited results for the year ended 31 March 2025. Turnover of £2,281,394 (prior year £1,891,065). Growth of 21%. Compound annual growth rate for underlying turnover, 2022 to 2025, of 39%. Gross profit margin of 47% (43%). Cash at year end £964,555 (£1,887,904).
Comment: The market put shares of TTA in the wrong place after the mini-fundraise that it did in the spring, something which in the wake of today’s strong announcement offers a decent entry point for those who like the mix of real world applications of technology.
Microlise Group (SAAS), a leading provider of transport management software to fleet operators, announces its unaudited results for the six months ended 30 June 2025. ARR growth of 8.7% to £58.7m (H1 2024: 20.6% and £54.0m) supported by several major direct customer contract wins and extensions in the period. Adjusted EBITDA increased 19% to £6.2m (H1 2024: £5.2m). Adjusted EBITDA margin has increased to 14.1% (H1 2024: 13.4%). The Group’s net cash at 30 June 2025 increased 24.7% to £11.2m (30 June 2024: £8.9m), after payment of a £1.4m final dividend in respect of 2024.
Comment: Shares of SAAS recently hit our rather ambitious 145p charting target, having rallied well over the summer. Today’s update, especially the strong cash position for this dividend payer, suggests that a full blown recovery from last year’s cyber incident is ongoing.
European Green Transition: From Exploration to Execution at The Investor Summit
SolGold (SOLG) reported a year of transformational progress, highlighted by a US$750 million stream financing, the acceleration of the Cascabel Feasibility Study, the completion of the Project Execution Plan, and the establishment of the ExploreCo strategy. Since year-end, the Company has drawn the second tranche of stream funding and advanced early works planning, rapidly building on the foundation established in the previous fiscal year. The Company ended fiscal 2025 with a cash balance of US$11.8 million, and has since strengthened its position with a further US$33.3 million drawdown.
Comment: Shares of SOLG more than doubled between mid-July and mid-September. Once the dust settles on today’s update it would be logical to look for a 20p share price target versus 15p currently. The year so far has been a mix between falling off a log and a victory lap.
AltynGold (ALTN), a leading exploration, production and development gold producer operating in Kazakhstan, announced its unaudited results for the six months to 30 June 2025. Adjusted EBITDA of US$44m (H1 2024: US$19.6m), “a compelling” 125% increase. ALTN said “The upgrade of the processing plant at the Sekisovskoye mine, completed in Q4 2024, is showing positive results, with gold production increasing considerably, by 44% YoY to 25,081oz, allowing AltynGold to benefit from the favorable gold price environment. The increased milling capacity and efficient operations have translated into record financial performance with an 125% increase in EBITDA from H1 2024. AltynGold continues to reiterate its production guidance of 50,000oz for the full year of 2025.”
Comment: Compelling indeed, with ALTN ramping up production at just the right time as gold hits fresh highs almost by the day. Any dips towards the 50 day moving average / 700p zone will probably be welcomed by momentum traders.
Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that the Company has signed an agreement for a specialist blood cancer trials organisation, Accelerating Clinical Trials Limited (“ACT”), to conduct the upcoming POLB 001 Phase 2a trial and has also secured the supply of an approved bispecific antibody drug for the trial at no cost to the Company.
Comment: It is ironic that POLB always looked to be a front runner as far as the baby biotechs on the London market, but so far has been rather left behind in the overall rally in the space this year. Ideally today’s announcement will start to change this state of affairs.
Arecor Therapeutics (AREC) announced a co-development agreement with a US Insulin pump device company for AT278 and the sale of royalty and technology access fees for up to $11 million, as well as its interim results for the six months to 30 June 2025.
Comment: This announcement has led to shares of AREC more than doubling since the beginning of July, just beating our second rather ambitious 89p technical target on the shares. This is something which may be just the beginning of a turnaround as the company chases moving to profitability.
GENinCode (GENI), the predictive genetics company focused on the prevention of cardiovascular disease (“CVD”) and risk of ovarian cancer announces its collaboration with the North Central London (NCL) Cancer Alliance and University College London Hospitals NHS Foundation Trust (UCLH), which becomes the first hospital trust in the UK to provide the Risk of Ovarian Cancer Algorithm (ROCA) surveillance test service as part of its Familial Cancer Clinic. The service, in line with new NICE guidance1, is for women who have a high risk of ovarian cancer due to inherited BRCA1 or BRCA2 gene alterations, who wish to defer preventative surgery.
Comment: Shares of GENI have already tripled so far this month, so clearly one or two people are onto the latest winner in the great stock market biotech rebound of 2025. Chart wise we could still see a squeeze as high as 7p, as long as it is not better to travel than arrive.
ZOO Digital Group (ZOO), the tech-enabled localisation and digital media services partner to the global entertainment industry, will hold its AGM at 5.00pm BST today. At the meeting, Gillian Wilmot, Chairman, will make the following statement: “The evolution of our operating environment continues, with streaming platforms now taking the majority of TV viewing time and content strategies evolving at pace to bring in new customers and engage existing viewers. As a result, we are currently seeing increased levels of licensing of existing content rather than new original content, a growing interest from streamers for live and near live content, and customers looking for localisation partners to utilise AI to increase speed and lower costs.”
Comment: Given the gold rush, or at least content rush in its space, ZOO should be in a rather better place in terms of its stock market trajectory than it currently is. Today’s AGM statement will need to do a lot of heavy lifting.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
